terfenadine has been researched along with Liver Diseases in 3 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fexofenadine is a highly specific, H1-receptor antagonist with a safety profile similar to placebo." | 2.40 | The systemic safety of fexofenadine HCl. ( Mason, J; Rao, N; Reynolds, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, S | 1 |
| Mason, J | 1 |
| Reynolds, R | 1 |
| Rao, N | 1 |
1 review available for terfenadine and Liver Diseases
| Article | Year |
|---|---|
The systemic safety of fexofenadine HCl.
Topics: Aged; Child; Drug Interactions; Drug Overdose; Histamine H1 Antagonists; Humans; Kidney Diseases; Li | 1999 |
2 other studies available for terfenadine and Liver Diseases
| Article | Year |
|---|---|
Dangers of non-sedating antihistamines.
Topics: Arrhythmias, Cardiac; Astemizole; Cetirizine; Heart Diseases; Histamine H1 Antagonists; Humans; Legi | 1997 |
Special drug communication teleconference. August 7, 1992.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Astemizole; Contraindications; Drug Incompatibility; Dr | 1992 |